DBT 30180
Alternative Names: DBT-30180Latest Information Update: 18 Dec 2023
At a glance
- Originator Diverse Biotech
- Class 2 ring heterocyclic compounds; Amides; Antineoplastics; Imidazoles; Small molecules; Triazenes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Glioblastoma